{"transactions":[{"id":730205,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":36276,"kind":"person","name":"Glibert Christian Michael","position":1,"cik":"0002111050","reported_name":"Glibert Christian Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"No longer subject to section 1"}}],"security":"Common Stock","published_at":"2026-06-22T17:43:24.000Z","date":"2026-06-22","kind":"sale","planned":false,"acquired":false,"shares":210000,"price":0.688,"value":144480.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were sold in multiple transactions ranging from $.6756 to $.722."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0002111050-26-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000211105026000007/primary_doc.xml","form_type":"4"}},{"id":805278,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":36276,"kind":"person","name":"Glibert Christian Michael","position":1,"cik":"0002111050","reported_name":"Glibert Christian Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"No longer a 10% holder"}}],"security":"Common Stock","published_at":"2026-04-17T21:10:54.000Z","date":"2026-04-15","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's percentage of beneficial ownership dropped below 10 percent due to dilution resulting from the Issuer's issuance of shares in connection with a merger, as reported in the Issuer's Form 10-K filed on April 15, 2026. No shares were disposed of or acquired by the Reporting Person."}],"balance_after":240000,"source":{"system":"sec-edgar","filing":"0002111050-26-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000211105026000005/primary_doc.xml","form_type":"4"}},{"id":909637,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":36276,"kind":"person","name":"Glibert Christian Michael","position":1,"cik":"0002111050","reported_name":"Glibert Christian Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2026-02-11T23:52:48.000Z","date":"2026-01-14","kind":"purchase","planned":false,"acquired":true,"shares":240000,"price":2.67,"value":640800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.47 to $2.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The percentage of ownership is based on 1,088,192 shares of Common Stock outstanding as of the Issuer's most recent filings in February 2026."}],"balance_after":240000,"source":{"system":"sec-edgar","filing":"0002111050-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000211105026000002/primary_doc.xml","form_type":"4"}},{"id":14727,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":100,"price":3.05,"value":305.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":231138,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14726,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":100,"price":3.07,"value":307.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":231238,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14725,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":10,"price":3.05,"value":30.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":231338,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14724,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":90,"price":3.05,"value":274.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":231348,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14723,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":100,"price":3.07,"value":307.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":231438,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14722,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":50,"price":3.05,"value":152.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":231538,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14721,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":100,"price":3.06,"value":306.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":231588,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14720,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":50,"price":3.05,"value":152.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":231688,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14719,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":82,"price":3.05,"value":250.1,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":231738,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14718,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":98,"price":3.05,"value":298.9,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":231820,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14717,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":417,"price":3.05,"value":1271.85,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":231918,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14716,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":50,"price":3.05,"value":152.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":232335,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14715,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":2,"price":3.05,"value":6.1,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":232385,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14714,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":183,"price":3.05,"value":558.15,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":232387,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14713,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":100,"price":3.05,"value":305.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":232570,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14712,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":100,"price":3.05,"value":305.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":232670,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14711,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":50,"price":3.05,"value":152.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":232770,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14710,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":100,"price":3.05,"value":305.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":232820,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14709,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":50,"price":3.05,"value":152.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":232920,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14708,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":18,"price":3.05,"value":54.9,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":232970,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14707,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":50,"price":3.05,"value":152.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":232988,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14706,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":50,"price":3.05,"value":152.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":233038,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14705,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":50,"price":3.05,"value":152.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":233088,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14704,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":500,"price":3.05,"value":1525.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":233138,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14703,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":200,"price":3.06,"value":612.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":233638,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14702,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":100,"price":3.04,"value":304.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":233838,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14701,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":4,"price":3.05,"value":12.2,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":233938,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14700,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":4,"price":3.05,"value":12.2,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":233942,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14699,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":10,"price":3.05,"value":30.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":233946,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":14698,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":2801,"kind":"organization","name":"BANK OF AMERICA CORP /DE/","symbol":"BAC","position":1,"cik":"0000070858","reported_name":"BANK OF AMERICA CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10539,"kind":"organization","name":"BOFA SECURITIES, INC.","position":2,"cik":"0001675365","reported_name":"BOFA SECURITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10345,"kind":"organization","name":"BANK OF AMERICA NA","position":3,"cik":"0001102113","reported_name":"BANK OF AMERICA NA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T02:03:17.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":100,"price":3.05,"value":305.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I (\"the Securities\") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer."}],"balance_after":233956,"source":{"system":"sec-edgar","filing":"0000070858-26-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70858/000007085826000030/primary_doc.xml","form_type":"4"}},{"id":1314818,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2025-01-03T16:05:16.000Z","date":"2024-12-30","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options vested on the date of grant in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2024 Long-Term Incentive Plan."}],"balance_after":80000,"derivative":{"exercise_price":0.5995,"expiration_date":"2034-12-30","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-25-000235","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315225000235/ownership.xml","form_type":"4"}},{"id":1318388,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84593,"kind":"person","name":"Schroeder Maria","position":1,"cik":"0001906106","reported_name":"Schroeder Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2025-01-03T02:23:31.000Z","date":"2024-12-30","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options vested on the date of grant in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2024 Long-Term Incentive Plan."}],"balance_after":20000,"derivative":{"exercise_price":0.5995,"expiration_date":"2034-12-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-25-000138","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315225000138/ownership.xml","form_type":"4"}},{"id":1318387,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2025-01-03T02:21:43.000Z","date":"2024-12-30","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options vested on the date of grant in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2024 Long-Term Incentive Plan."}],"balance_after":20000,"derivative":{"exercise_price":0.5995,"expiration_date":"2034-12-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-25-000136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315225000136/ownership.xml","form_type":"4"}},{"id":1318386,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84591,"kind":"person","name":"Cassirer Aurora","position":1,"cik":"0001905696","reported_name":"Cassirer Aurora","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2025-01-03T02:18:10.000Z","date":"2024-12-30","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options vested on the date of grant in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2024 Long-Term Incentive Plan."}],"balance_after":20000,"derivative":{"exercise_price":0.5995,"expiration_date":"2034-12-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-25-000133","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315225000133/ownership.xml","form_type":"4"}},{"id":1318460,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84597,"kind":"person","name":"MIKA THOMAS","position":1,"cik":"0001263576","reported_name":"MIKA THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2025-01-02T21:26:30.000Z","date":"2024-12-30","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options vested on the date of grant in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2024 Long-Term Incentive Plan."}],"balance_after":20000,"derivative":{"exercise_price":0.5995,"expiration_date":"2034-12-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-25-000141","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263576/000149315225000141/ownership.xml","form_type":"4"}},{"id":1318446,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84596,"kind":"person","name":"BROWN STEPHEN RUSSELL","position":1,"cik":"0001246334","reported_name":"BROWN STEPHEN RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2025-01-02T21:25:07.000Z","date":"2024-12-30","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options vested on the date of grant in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2024 Long-Term Incentive Plan."}],"balance_after":50000,"derivative":{"exercise_price":0.5995,"expiration_date":"2034-12-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-25-000139","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246334/000149315225000139/ownership.xml","form_type":"4"}},{"id":1318616,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84609,"kind":"person","name":"Goldstein Martin M","position":1,"cik":"0001639061","reported_name":"Goldstein Martin M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2025-01-02T21:22:42.000Z","date":"2024-12-30","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options vested on the date of grant in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2024 Long-Term Incentive Plan."}],"balance_after":23000,"derivative":{"exercise_price":0.5995,"expiration_date":"2034-12-30","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001493152-25-000137","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639061/000149315225000137/ownership.xml","form_type":"4"}},{"id":1318553,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84601,"kind":"person","name":"JACOB HAROLD","position":1,"cik":"0001443692","reported_name":"JACOB HAROLD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2025-01-02T21:20:35.000Z","date":"2024-12-30","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options vested on the date of grant in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2024 Long-Term Incentive Plan."}],"balance_after":10000,"derivative":{"exercise_price":0.5995,"expiration_date":"2034-12-30","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-25-000135","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443692/000149315225000135/ownership.xml","form_type":"4"}},{"id":1318491,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84598,"kind":"person","name":"FASHEK CHRISTOPHER M","position":1,"cik":"0001279063","reported_name":"FASHEK CHRISTOPHER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2025-01-02T21:19:33.000Z","date":"2024-12-30","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options vested on the date of grant in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2024 Long-Term Incentive Plan."}],"balance_after":50000,"derivative":{"exercise_price":0.5995,"expiration_date":"2034-12-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-25-000134","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279063/000149315225000134/ownership.xml","form_type":"4"}},{"id":1619001,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84597,"kind":"person","name":"MIKA THOMAS","position":1,"cik":"0001263576","reported_name":"MIKA THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-26T20:36:11.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on January 23, 2024, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":16666,"derivative":{"exercise_price":0.9,"expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001493152-24-007898","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263576/000149315224007898/ownership.xml","form_type":"4"}},{"id":1619205,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84601,"kind":"person","name":"JACOB HAROLD","position":1,"cik":"0001443692","reported_name":"JACOB HAROLD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-26T17:32:19.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on January 23, 2024, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":6667,"derivative":{"exercise_price":0.9,"expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001493152-24-007856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443692/000149315224007856/ownership.xml","form_type":"4"}},{"id":1622126,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84593,"kind":"person","name":"Schroeder Maria","position":1,"cik":"0001906106","reported_name":"Schroeder Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-24T00:19:35.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on January 23, 2024, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":16667,"derivative":{"exercise_price":0.9,"expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001493152-24-007745","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315224007745/ownership.xml","form_type":"4"}},{"id":1622125,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-24T00:18:21.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on January 23, 2024, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":16666,"derivative":{"exercise_price":0.9,"expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001493152-24-007743","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315224007743/ownership.xml","form_type":"4"}},{"id":1622124,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84591,"kind":"person","name":"Cassirer Aurora","position":1,"cik":"0001905696","reported_name":"Cassirer Aurora","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-24T00:15:46.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on January 23, 2024, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":16667,"derivative":{"exercise_price":0.9,"expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001493152-24-007739","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315224007739/ownership.xml","form_type":"4"}},{"id":1622507,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84609,"kind":"person","name":"Goldstein Martin M","position":1,"cik":"0001639061","reported_name":"Goldstein Martin M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-23T19:17:10.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on January 23, 2024, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":16667,"derivative":{"exercise_price":0.9,"expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001493152-24-007741","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639061/000149315224007741/ownership.xml","form_type":"4"}},{"id":1720113,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-06T16:45:11.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the option vested on December 29, 2021 (the \" 2021 Date of Grant\"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":20.2,"expiration_date":"2031-12-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-23-043893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315223043893/ownership.xml","form_type":"4"}},{"id":1720112,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-06T16:45:11.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"20% of the option vested on December 22, 2020 (the \"2020 Date of Grant\"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":16.8,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-23-043893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315223043893/ownership.xml","form_type":"4"}},{"id":1720111,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-06T16:45:11.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations"}],"balance_after":0,"derivative":{"exercise_price":14.1,"exercise_date":"2020-10-01","expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001493152-23-043893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315223043893/ownership.xml","form_type":"4"}},{"id":1720110,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-06T16:45:11.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in two equal installments as follows: (i) 1/2 of the total shares on November 1, 2018, and (ii) 1/2 of the total shares on November 1, 2019."}],"balance_after":0,"derivative":{"exercise_price":8.94,"expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001493152-23-043893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315223043893/ownership.xml","form_type":"4"}},{"id":1720109,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-06T16:45:11.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":20000,"derivative":{"exercise_price":1.24,"expiration_date":"2023-11-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-23-043893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315223043893/ownership.xml","form_type":"4"}},{"id":1719947,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84598,"kind":"person","name":"FASHEK CHRISTOPHER M","position":1,"cik":"0001279063","reported_name":"FASHEK CHRISTOPHER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2023-12-06T16:45:09.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the option vested on December 29, 2021 (the \"2021 Date of Grant\"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":20.2,"expiration_date":"2031-12-28","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001493152-23-043892","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1279063/000149315223043892/ownership.xml","form_type":"4"}},{"id":1719946,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84598,"kind":"person","name":"FASHEK CHRISTOPHER M","position":1,"cik":"0001279063","reported_name":"FASHEK CHRISTOPHER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2023-12-06T16:45:09.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"20% of the option vested on December 22, 2020 (the \"2020 Date of Grant\"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":16.8,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001493152-23-043892","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1279063/000149315223043892/ownership.xml","form_type":"4"}},{"id":1719945,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84598,"kind":"person","name":"FASHEK CHRISTOPHER M","position":1,"cik":"0001279063","reported_name":"FASHEK CHRISTOPHER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2023-12-06T16:45:09.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."}],"balance_after":0,"derivative":{"exercise_price":14.4,"exercise_date":"2020-10-01","expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001493152-23-043892","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1279063/000149315223043892/ownership.xml","form_type":"4"}},{"id":1719944,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84598,"kind":"person","name":"FASHEK CHRISTOPHER M","position":1,"cik":"0001279063","reported_name":"FASHEK CHRISTOPHER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2023-12-06T16:45:09.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."}],"balance_after":0,"derivative":{"exercise_price":41.4,"exercise_date":"2020-07-07","expiration_date":"2030-07-07","underlying":"Common Stock","underlying_shares":2100},"source":{"system":"sec-edgar","filing":"0001493152-23-043892","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1279063/000149315223043892/ownership.xml","form_type":"4"}},{"id":1719943,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84598,"kind":"person","name":"FASHEK CHRISTOPHER M","position":1,"cik":"0001279063","reported_name":"FASHEK CHRISTOPHER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2023-12-06T16:45:09.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in two equal installments as follows: (i) 1/2 of the total shares on November 1, 2018, and (ii) 1/2 of the total shares on November 1, 2019."}],"balance_after":0,"derivative":{"exercise_price":20.2,"expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001493152-23-043892","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279063/000149315223043892/ownership.xml","form_type":"4"}},{"id":1719942,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84598,"kind":"person","name":"FASHEK CHRISTOPHER M","position":1,"cik":"0001279063","reported_name":"FASHEK CHRISTOPHER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-06T16:45:09.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":14000,"derivative":{"exercise_price":1.24,"expiration_date":"2033-11-15","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001493152-23-043892","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279063/000149315223043892/ownership.xml","form_type":"4"}},{"id":1723560,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84593,"kind":"person","name":"Schroeder Maria","position":1,"cik":"0001906106","reported_name":"Schroeder Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:09.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option vested on September 13, 2022 (the \"2022 Date of Grant\"), with an additional 25% to vest on the three-month anniversary of the 2022 Date of Grant, a further 25% to vest on the six-month anniversary of the 2022 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2022 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":8.94,"expiration_date":"2032-09-13","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001493152-23-043632","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043632/ownership.xml","form_type":"4"}},{"id":1723559,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84593,"kind":"person","name":"Schroeder Maria","position":1,"cik":"0001906106","reported_name":"Schroeder Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:09.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":3333,"derivative":{"exercise_price":1.24,"expiration_date":"2033-11-15","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001493152-23-043632","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043632/ownership.xml","form_type":"4"}},{"id":1723558,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84591,"kind":"person","name":"Cassirer Aurora","position":1,"cik":"0001905696","reported_name":"Cassirer Aurora","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:02.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option vested on September 13, 2022 (the \"2022 Date of Grant\"), with an additional 25% to vest on the three-month anniversary of the 2022 Date of Grant, a further 25% to vest on the six-month anniversary of the 2022 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2022 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":8.94,"expiration_date":"2032-09-13","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001493152-23-043636","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043636/ownership.xml","form_type":"4"}},{"id":1723557,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84591,"kind":"person","name":"Cassirer Aurora","position":1,"cik":"0001905696","reported_name":"Cassirer Aurora","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:02.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":3333,"derivative":{"exercise_price":1.24,"expiration_date":"2033-11-15","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001493152-23-043636","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043636/ownership.xml","form_type":"4"}},{"id":1723556,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:02.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the option vested on September 13, 2022 (the \"2022 Date of Grant\"), with an additional 25% to vest on the three-month anniversary of the 2022 Date of Grant, a further 25% to vest on the six-month anniversary of the 2022 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2022 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":8.94,"expiration_date":"2032-09-13","underlying":"Common Stock","underlying_shares":2875},"source":{"system":"sec-edgar","filing":"0001493152-23-043635","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043635/ownership.xml","form_type":"4"}},{"id":1723555,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:02.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the option vested on December 29, 2021 (the \" 2021 Date of Grant\"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":20.2,"expiration_date":"2031-12-29","underlying":"Common Stock","underlying_shares":2875},"source":{"system":"sec-edgar","filing":"0001493152-23-043635","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043635/ownership.xml","form_type":"4"}},{"id":1723554,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:02.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"20% of the option vested on December 22, 2020 (the \"2020 Date of Grant\"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":16.8,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001493152-23-043635","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043635/ownership.xml","form_type":"4"}},{"id":1723553,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:02.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."}],"balance_after":0,"derivative":{"exercise_price":14.4,"exercise_date":"2020-10-01","expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001493152-23-043635","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043635/ownership.xml","form_type":"4"}},{"id":1723552,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:02.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":3334,"derivative":{"exercise_price":1.24,"expiration_date":"2023-11-15","underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001493152-23-043635","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043635/ownership.xml","form_type":"4"}},{"id":1723617,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84597,"kind":"person","name":"MIKA THOMAS","position":1,"cik":"0001263576","reported_name":"MIKA THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:11.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the option vested on December 29, 2021 (the \" 2021 Date of Grant\"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":20.2,"expiration_date":"2031-12-29","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001493152-23-043633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1263576/000149315223043633/ownership.xml","form_type":"4"}},{"id":1723616,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84597,"kind":"person","name":"MIKA THOMAS","position":1,"cik":"0001263576","reported_name":"MIKA THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:11.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"20% of the option vested on December 22, 2020 (the \"2020 Date of Grant\"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":16.8,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001493152-23-043633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1263576/000149315223043633/ownership.xml","form_type":"4"}},{"id":1723615,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84597,"kind":"person","name":"MIKA THOMAS","position":1,"cik":"0001263576","reported_name":"MIKA THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:11.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."}],"balance_after":0,"derivative":{"exercise_price":14.4,"exercise_date":"2020-10-01","expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001493152-23-043633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1263576/000149315223043633/ownership.xml","form_type":"4"}},{"id":1723614,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84597,"kind":"person","name":"MIKA THOMAS","position":1,"cik":"0001263576","reported_name":"MIKA THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:11.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option vested on September 13, 2022 (the \"2022 Date of Grant\"), with an additional 25% to vest on the three-month anniversary of the 2022 Date of Grant, a further 25% to vest on the six-month anniversary of the 2022 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2022 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":8.94,"expiration_date":"2032-09-13","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001493152-23-043633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263576/000149315223043633/ownership.xml","form_type":"4"}},{"id":1723613,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84597,"kind":"person","name":"MIKA THOMAS","position":1,"cik":"0001263576","reported_name":"MIKA THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:11.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."}],"balance_after":0,"derivative":{"exercise_price":32,"exercise_date":"2020-07-13","expiration_date":"2030-07-13","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001493152-23-043633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263576/000149315223043633/ownership.xml","form_type":"4"}},{"id":1723612,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84597,"kind":"person","name":"MIKA THOMAS","position":1,"cik":"0001263576","reported_name":"MIKA THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:11.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":3334,"derivative":{"exercise_price":1.24,"expiration_date":"2033-11-15","underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001493152-23-043633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263576/000149315223043633/ownership.xml","form_type":"4"}},{"id":1723843,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84609,"kind":"person","name":"Goldstein Martin M","position":1,"cik":"0001639061","reported_name":"Goldstein Martin M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:08.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the option vested on September 13, 2022 (the \"2022 Date of Grant\"), with an additional 25% to vest on the three-month anniversary of the 2022 Date of Grant, a further 25% to vest on the six-month anniversary of the 2022 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2022 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":8.94,"expiration_date":"2032-09-13","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001493152-23-043638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1639061/000149315223043638/ownership.xml","form_type":"4"}},{"id":1723842,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84609,"kind":"person","name":"Goldstein Martin M","position":1,"cik":"0001639061","reported_name":"Goldstein Martin M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:08.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the option vested on December 29, 2021 (the \" 2021 Date of Grant\"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":20.2,"expiration_date":"2031-12-29","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001493152-23-043638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1639061/000149315223043638/ownership.xml","form_type":"4"}},{"id":1723841,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84609,"kind":"person","name":"Goldstein Martin M","position":1,"cik":"0001639061","reported_name":"Goldstein Martin M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:08.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"20% of the option vested on December 22, 2020 (the \"2020 Date of Grant\"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":16.8,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001493152-23-043638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1639061/000149315223043638/ownership.xml","form_type":"4"}},{"id":1723840,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84609,"kind":"person","name":"Goldstein Martin M","position":1,"cik":"0001639061","reported_name":"Goldstein Martin M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:08.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."}],"balance_after":0,"derivative":{"exercise_price":14.4,"exercise_date":"2020-10-01","expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001493152-23-043638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1639061/000149315223043638/ownership.xml","form_type":"4"}},{"id":1723839,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84609,"kind":"person","name":"Goldstein Martin M","position":1,"cik":"0001639061","reported_name":"Goldstein Martin M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:08.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."}],"balance_after":0,"derivative":{"exercise_price":32,"exercise_date":"2020-07-13","expiration_date":"2030-07-13","underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001493152-23-043638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1639061/000149315223043638/ownership.xml","form_type":"4"}},{"id":1723838,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84609,"kind":"person","name":"Goldstein Martin M","position":1,"cik":"0001639061","reported_name":"Goldstein Martin M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:08.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"20% of the option vested on March 25, 2015 (the \"2015 Date of Grant\"), with an additional 20% vested on the three month anniversary of the 2015 Date of Grant, a further 20% vested on the six month anniversary of the 2015 Date of Grant, a further 20% vested on the nine month anniversary of the 2015 Date of Grant, and the final 20% vested on the year anniversary of the 2015 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":51.4,"expiration_date":"2035-03-25","underlying":"Common Stock","underlying_shares":4575},"source":{"system":"sec-edgar","filing":"0001493152-23-043638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639061/000149315223043638/ownership.xml","form_type":"4"}},{"id":1723837,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84609,"kind":"person","name":"Goldstein Martin M","position":1,"cik":"0001639061","reported_name":"Goldstein Martin M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:08.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":3333,"derivative":{"exercise_price":1.24,"expiration_date":"2033-11-15","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001493152-23-043638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639061/000149315223043638/ownership.xml","form_type":"4"}},{"id":1723740,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84601,"kind":"person","name":"JACOB HAROLD","position":1,"cik":"0001443692","reported_name":"JACOB HAROLD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:06.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the option vested on September 13, 2022 (the \"2022 Date of Grant\"), with an additional 25% to vest on the three-month anniversary of the 2022 Date of Grant, a further 25% to vest on the six-month anniversary of the 2022 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2022 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":8.94,"expiration_date":"2032-09-13","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001493152-23-043634","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443692/000149315223043634/ownership.xml","form_type":"4"}},{"id":1723739,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84601,"kind":"person","name":"JACOB HAROLD","position":1,"cik":"0001443692","reported_name":"JACOB HAROLD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:06.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option vested on December 29, 2021 (the \"2021 Date of Grant\"), with an additional 25% to vest on the three-month anniversary of the 2021 Date of Grant, a further 25% to vest on the six-month anniversary of the 2021 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":20.2,"expiration_date":"2031-12-29","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001493152-23-043634","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443692/000149315223043634/ownership.xml","form_type":"4"}},{"id":1723738,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84601,"kind":"person","name":"JACOB HAROLD","position":1,"cik":"0001443692","reported_name":"JACOB HAROLD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:06.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":3333,"derivative":{"exercise_price":1.24,"expiration_date":"2033-11-15","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001493152-23-043634","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443692/000149315223043634/ownership.xml","form_type":"4"}},{"id":1723605,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84596,"kind":"person","name":"BROWN STEPHEN RUSSELL","position":1,"cik":"0001246334","reported_name":"BROWN STEPHEN RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:06.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the option vested on December 29, 2021 (the \" 2021 Date of Grant\"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":20.2,"expiration_date":"2031-12-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-23-043637","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246334/000149315223043637/ownership.xml","form_type":"4"}},{"id":1723604,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84596,"kind":"person","name":"BROWN STEPHEN RUSSELL","position":1,"cik":"0001246334","reported_name":"BROWN STEPHEN RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:06.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"20% of the option vested on December 22, 2020 (the \"2020 Date of Grant\"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":16.8,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001493152-23-043637","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246334/000149315223043637/ownership.xml","form_type":"4"}},{"id":1723603,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84596,"kind":"person","name":"BROWN STEPHEN RUSSELL","position":1,"cik":"0001246334","reported_name":"BROWN STEPHEN RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:06.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."}],"balance_after":0,"derivative":{"exercise_price":14.4,"exercise_date":"2020-10-01","expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001493152-23-043637","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246334/000149315223043637/ownership.xml","form_type":"4"}},{"id":1723602,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84596,"kind":"person","name":"BROWN STEPHEN RUSSELL","position":1,"cik":"0001246334","reported_name":"BROWN STEPHEN RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:06.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in two equal installments as follows: (i) 1/2 of the total shares on November 1, 2018, and (ii) 1/2 of the total shares on November 1, 2019."}],"balance_after":0,"derivative":{"exercise_price":8.84,"expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":563},"source":{"system":"sec-edgar","filing":"0001493152-23-043637","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246334/000149315223043637/ownership.xml","form_type":"4"}},{"id":1723601,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84596,"kind":"person","name":"BROWN STEPHEN RUSSELL","position":1,"cik":"0001246334","reported_name":"BROWN STEPHEN RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-04T20:45:06.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":14000,"derivative":{"exercise_price":1.24,"expiration_date":"2033-11-15","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001493152-23-043637","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246334/000149315223043637/ownership.xml","form_type":"4"}},{"id":2062197,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84597,"kind":"person","name":"MIKA THOMAS","position":1,"cik":"0001263576","reported_name":"MIKA THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T16:05:52.000Z","date":"2023-01-05","kind":"purchase","acquired":true,"shares":50000,"price":0.25,"value":12500.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001493152-23-000609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263576/000149315223000609/ownership.xml","form_type":"4"}},{"id":2227343,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84598,"kind":"person","name":"FASHEK CHRISTOPHER M","position":1,"cik":"0001279063","reported_name":"FASHEK CHRISTOPHER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T16:17:50.000Z","date":"2022-06-15","kind":"purchase","acquired":true,"shares":40000,"price":0.5957,"value":23828.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects shares of common stock the reporting person purchased on November 20, 2019, which were inadvertently excluded from the Form 4 filed on September 29, 2020."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001493152-22-017169","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279063/000149315222017169/ownership.xml","form_type":"4"}},{"id":2227341,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84598,"kind":"person","name":"FASHEK CHRISTOPHER M","position":1,"cik":"0001279063","reported_name":"FASHEK CHRISTOPHER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T16:15:31.000Z","date":"2019-11-20","kind":"purchase","acquired":true,"shares":25000,"price":2,"value":50000.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001493152-22-017164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279063/000149315222017164/ownership.xml","form_type":"4"}},{"id":2232442,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84596,"kind":"person","name":"BROWN STEPHEN RUSSELL","position":1,"cik":"0001246334","reported_name":"BROWN STEPHEN RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-14T16:15:29.000Z","date":"2022-06-14","kind":"purchase","acquired":true,"shares":4000,"price":0.5739,"value":2295.6,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001493152-22-016736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246334/000149315222016736/ownership.xml","form_type":"4"}},{"id":2247120,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84591,"kind":"person","name":"Cassirer Aurora","position":1,"cik":"0001905696","reported_name":"Cassirer Aurora","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T10:10:17.000Z","date":"2022-06-01","kind":"purchase","acquired":true,"shares":2000,"price":0.69,"value":1380.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001493152-22-015656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315222015656/ownership.xml","form_type":"4"}},{"id":2454163,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84601,"kind":"person","name":"JACOB HAROLD","position":1,"cik":"0001443692","reported_name":"JACOB HAROLD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-01-03T13:52:51.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option vested on December 29, 2021 (the \"Date of Grant\"), with an additional 25% to vest on the three-month anniversary of the Date of Grant, a\nfurther 25% to vest on the six-month anniversary of the Date of Grant, and the final 25% to vest on the nine-month anniversary of the Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":50000,"derivative":{"exercise_price":1.01,"expiration_date":"2031-12-28","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-000081","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443692/000149315222000081/ownership.xml","form_type":"4"}},{"id":2454321,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-01-03T13:47:58.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal installments on each three-month anniversary of the grant date (December 29, 2021), in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":300000,"derivative":{"exercise_price":1.01,"expiration_date":"2031-12-28","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-22-000078","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315222000078/ownership.xml","form_type":"4"}},{"id":2453977,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84597,"kind":"person","name":"MIKA THOMAS","position":1,"cik":"0001263576","reported_name":"MIKA THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2022-01-03T13:43:55.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option vested on December 29, 2021 (the \"Date of Grant\"), with an additional 25% to vest on the three-month anniversary of the Date of Grant, a\nfurther 25% to vest on the six-month anniversary of the Date of Grant, and the final 25% to vest on the nine-month anniversary of the Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":60000,"derivative":{"exercise_price":1.01,"expiration_date":"2031-12-28","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001493152-22-000075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263576/000149315222000075/ownership.xml","form_type":"4"}},{"id":2454019,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84598,"kind":"person","name":"FASHEK CHRISTOPHER M","position":1,"cik":"0001279063","reported_name":"FASHEK CHRISTOPHER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2022-01-03T13:41:00.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option vested on December 29, 2021 (the \"Date of Grant\"), with an additional 25% to vest on the three-month anniversary of the Date of Grant, a further 25% to vest on the six-month anniversary of the Date of Grant, and the final 25% to vest on the nine-month anniversary of the Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":80000,"derivative":{"exercise_price":1.01,"expiration_date":"2031-12-28","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-22-000073","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279063/000149315222000073/ownership.xml","form_type":"4"}},{"id":2456039,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-12-30T22:01:26.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option vested on December 29, 2021 (the \"Date of Grant\"), with an additional 25% to vest on the three-month anniversary of the Date of Grant, a\nfurther 25% to vest on the six-month anniversary of the Date of Grant, and the final 25% to vest on the nine-month anniversary of the Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":57500,"derivative":{"exercise_price":1.01,"expiration_date":"2031-12-28","underlying":"Common Stock","underlying_shares":57500},"source":{"system":"sec-edgar","filing":"0001493152-21-032873","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315221032873/ownership.xml","form_type":"4"}},{"id":2456094,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84596,"kind":"person","name":"BROWN STEPHEN RUSSELL","position":1,"cik":"0001246334","reported_name":"BROWN STEPHEN RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2021-12-30T17:03:09.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal installments on each three-month anniversary of the grant date (December 29, 2021), in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":100000,"derivative":{"exercise_price":1.01,"expiration_date":"2031-12-28","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-21-032877","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246334/000149315221032877/ownership.xml","form_type":"4"}}],"next_cursor":"2021-12-30T17:03:09.000000Z,2456094"}